FLIP THE SWITCH
Live / Allowed — Notice of allowance issued (as of 25 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99334810
- Mark type
- Stylized text
- Filed
- 13 Aug 2025
- Published for opposition
- 30 Sept 2025
- Attorney of record
- Brian Focarino
Goods and services
- Class 044 — Medical, beauty and agricultural services: Patient advisory, support and consultancy services regarding access to medical treatment of hereditary angioedema; providing healthcare information, medical information, and pharmaceutical advice online, by telephone, and through distribution of printed healthcare materials to healthcare providers, patients, physicians, medical office staff, pharmaceutical prescribers, caregivers, and pharmacies regarding patient access to and reimbursement for pharmaceuticals and safe and appropriate use and distribution of pharmaceuticals; providing a website featuring medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the field of hereditary angioedema and edema diseases and disorders, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; medical consulting services in the field of hereditary angioedema and edema diseases and disorders, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of hereditary angioedema and edema diseases and disorders, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders, and collecting data and information on hereditary angioedema, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and collecting data and information on rare diseases and disorders for treatment and diagnostic purposes; providing medical and healthcare information
Owner
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
- Ionis Pharmaceuticals, Inc., Carlsbad, CA, US
Prosecution history
- 03 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Sept 2025 — PUBLISHED FOR OPPOSITION
- 24 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2025 — ASSIGNED TO EXAMINER
- 13 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Aug 2025 — NEW APPLICATION ENTERED